Cargando…
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data
Replication-competent (oncolytic) viruses (OV) as cancer immunotherapeutics have gained an increasing level of attention over the last few years while the clinical evidence of virus-mediated antitumor immune responses is still anecdotal. Multiple clinical studies are currently ongoing and more immun...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968310/ https://www.ncbi.nlm.nih.gov/pubmed/26176173 http://dx.doi.org/10.1089/hum.2015.055 |